首页> 美国卫生研究院文献>Clinical Kidney Journal >Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?
【2h】

Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?

机译:常规与生物相容性腹膜透析液:问题多于答案?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The most important challenge in peritoneal dialysis (PD) is long-term preservation of peritoneal membrane structure and function. Introduction of dialysis fluids into the peritoneal cavity induces changes. These changes are related to duration of dialysis, occurrence of peritonitis and components of the dialysis solution. Bioincompatibility is considered to be the major cause of the development of morphological changes of the peritoneal membrane. pH neutral PD fluids that are low in glucose degradation products (GDP) seem to better preserve the peritoneal membrane and have less systemic effects than the conventional ones. However, the long-term effects are not clear. An overview of the effects of conventional PD fluids and glucose-based PD fluids with neutral pH in ex vivo and in vivo animal and clinical studies is presented.
机译:腹膜透析(PD)中最重要的挑战是腹膜结构和功能的长期保存。将透析液引入腹膜腔引起变化。这些变化与透析的持续时间,腹膜炎的发生以及透析液的成分有关。生物相容性被认为是腹膜形态变化的主要原因。葡萄糖降解产物(GDP)含量低的pH中性PD液似乎比传统的液能更好地保护腹膜,并具有较小的全身作用。但是,长期影响尚不清楚。概述了常规PD液体和中性pH的葡萄糖基PD液体在离体和体内动物及临床研究中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号